Anesthesia Depth's Influence on Postoperative Delirium

Status Enrolling by invitation

Clinical Trial Summary

The investigators,according to the eligibility criteria,plane to choose 80 elderly anticipates who will undergo selective hip replacement surgery.This participants will be randomly divided into 2 groups:light anesthesia depth group(L Group) and deep anesthesia depth group (D Group).Before anesthesia induction,each participant will be given lumbar plexus and sciatic nerve block in order to control pain of interoperative and postoperative.During operation period,the L Group will be kept in light anesthesia depth(BIS:50-60),while the D group will be kept in deep anesthesia depth(BIS:35-45)--The BIS values in the range of 30-60 have been recommended in general anesthesia.After operation,a PCIA(patient controlled intravenous analgesia) analgesia pump will be given to each participant to control postoperative pain. The investigator will evaluate the mental state of participant with MMSE(mini-mental state examination) before surgery and review each participant with a CAM-CR for 3 days after surgery to assess the situation of postoperation delirium.intraoperative awareness,postoperative pain will also be investigated in postoperative days 1, 2, 3.

Clinical Trial Description

The investigators,according to the eligibility criteria,plane to choose 80 elderly participants who will undergo selective hip replacement surgery.This participants will be randomly divided into 2 groups:light anesthesia depth group(BIS:50-60) and deep anesthesia depth group (BIS:35-45)--The BIS values in the range of 30-60 have been recommended in general anesthesia.Before anesthesia induction,each participant will be given lumbar plexus and sciatic nerve block in order to control pain of intraoperative and postoperative.The investigator use propofol 4ug\kg、and sufentanil 0.2ug\kg during anesthesia induction period,after that,a Laryngeal mask will be placed into patient's mouth.Anesthesia is maintained with remifentanil TCI(target-controlled infusion) target-controlled infusion(concentration:2ng/ml) and propofol BIS closed-loop target-controlled infusion.During the operation period ,the investigator keep the L Group`s BIS range from 50 to 60.While the D Group`s BIS range from 35 to 45.All participants receive postoperative analgesia.After operation,all participants will be send to PACU(post-anaesthesia care unit ) to wake up and send back to ward,And a PCIA(patient controlled intravenous analgesia) analgesia pump will be given to each participants to control postoperative pain.The investigators will use MMSE(mini-mental state examination) to evaluate the participant's mental state before surgery.For 3 days after operation,The investigator will review each participant with a CAM-CR to assess the situation of postoperation delirium.The investigator will see if there is intraoperative awareness by asking questions.Postoperative pain(with VAS) will also be investigated in postoperative days 1, 2, 3. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02972762
Study type	Interventional
Source	Xiangya Hospital of Central South University
Contact
Status	Enrolling by invitation
Phase	Early Phase 1
Start date	November 2016
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02062437` - Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair	N/A
Completed	`NCT00393848` - Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery	Phase 2
Completed	`NCT01496300` - Benefit of Orthopedic Navigation in the ARThroplasty of the Hip	Phase 4
Completed	`NCT00244400` - Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis	N/A
Recruiting	`NCT02230826` - Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
Completed	`NCT02062450` - Observational Study Evaluating Outcomes of Hip Arthroplasty Using Tornier Dual Mobility Acetabular Cup	N/A
Active, not recruiting	`NCT02288117` - Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis Stem
Completed	`NCT02379663` - Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty	Phase 4
Enrolling by invitation	`NCT02365077` - GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese Population
Completed	`NCT02733900` - Modifications of the Subchondral Bone in Aseptic Osteonecrosis of the Femoral Head	N/A
Not yet recruiting	`NCT02633904` - Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH)	N/A
Withdrawn	`NCT02799654` - Excia T Cementless EBRA Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.